225 related articles for article (PubMed ID: 29626738)
21. Should low-income countries invest in breast cancer screening?
Gyawali B; Shimokata T; Honda K; Tsukuura H; Ando Y
Cancer Causes Control; 2016 Nov; 27(11):1341-1345. PubMed ID: 27680017
[TBL] [Abstract][Full Text] [Related]
22. Total Medicare Costs Associated With Diagnosis and Treatment of Prostate Cancer in Elderly Men.
Trogdon JG; Falchook AD; Basak R; Carpenter WR; Chen RC
JAMA Oncol; 2019 Jan; 5(1):60-66. PubMed ID: 30242397
[TBL] [Abstract][Full Text] [Related]
23. The costs of treating breast cancer in Australia and the implications for breast cancer screening.
Butler JR; Furnival CM; Hart RF
Aust N Z J Surg; 1995 Jul; 65(7):485-91. PubMed ID: 7611968
[TBL] [Abstract][Full Text] [Related]
24. A workplace breast cancer screening program. Costs and components.
Schrammel P; Griffiths RI; Griffiths CB
AAOHN J; 1998 Nov; 46(11):523-9. PubMed ID: 9934000
[TBL] [Abstract][Full Text] [Related]
25. A Health System-Based Investment Case for Adolescent Health.
Sweeny K; Friedman HS; Sheehan P; Fridman M; Shi H
J Adolesc Health; 2019 Jul; 65(1S):S8-S15. PubMed ID: 31228990
[TBL] [Abstract][Full Text] [Related]
26. Awardee-specific economic costs of providing cancer screening and health promotional services to medically underserved women eligible in the National Breast and Cervical Cancer Early Detection Program.
Subramanian S; Ekwueme DU; Miller JW; Khushalani JS; Trogdon JG; Wong FL
Cancer Causes Control; 2019 Aug; 30(8):827-834. PubMed ID: 31111278
[TBL] [Abstract][Full Text] [Related]
27. Will early detection of breast cancer reduce the costs of treatment?
Salkeld G; Gerard K
Aust J Public Health; 1994 Dec; 18(4):388-93. PubMed ID: 7718652
[TBL] [Abstract][Full Text] [Related]
28. Dutch digital breast cancer screening: implications for breast cancer care.
Timmers JM; den Heeten GJ; Adang EM; Otten JD; Verbeek AL; Broeders MJ
Eur J Public Health; 2012 Dec; 22(6):925-9. PubMed ID: 22158996
[TBL] [Abstract][Full Text] [Related]
29. Breast cancer screening: review of benefits and harms, and recommendations for developing and low-income countries.
Al-Foheidi M; Al-Mansour MM; Ibrahim EM
Med Oncol; 2013 Jun; 30(2):471. PubMed ID: 23420062
[TBL] [Abstract][Full Text] [Related]
30. Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004.
Ekwueme DU; Gardner JG; Subramanian S; Tangka FK; Bapat B; Richardson LC
Cancer; 2008 Feb; 112(3):626-35. PubMed ID: 18157831
[TBL] [Abstract][Full Text] [Related]
31. The Long-Term Effectiveness and Cost Effectiveness of Organized versus Opportunistic Screening for Breast Cancer in Austria.
Schiller-Fruehwirth I; Jahn B; Einzinger P; Zauner G; Urach C; Siebert U
Value Health; 2017 Sep; 20(8):1048-1057. PubMed ID: 28964436
[TBL] [Abstract][Full Text] [Related]
32. [Cost of breast cancer treatment by clinical stage in the Basque Country, Spain].
Arrospide A; Soto-Gordoa M; Acaiturri T; López-Vivanco G; Abecia LC; Mar J
Rev Esp Salud Publica; 2015; 89(1):93-7. PubMed ID: 25946589
[TBL] [Abstract][Full Text] [Related]
33. Return on Investment Analysis of Health Experts onLine at Portsmouth: A 2-Year Review of the Navy's Newest Teleconsultation System.
Lin AH; Welstead BL; Morey BL; Mahnke CB; Cole JH; Johnston MG
Mil Med; 2017 May; 182(5):e1696-e1701. PubMed ID: 29087913
[TBL] [Abstract][Full Text] [Related]
34. Developing and testing a cost-assessment tool for cancer screening programs.
Subramanian S; Ekwueme DU; Gardner JG; Trogdon J
Am J Prev Med; 2009 Sep; 37(3):242-7. PubMed ID: 19666160
[TBL] [Abstract][Full Text] [Related]
35. Community Asthma Initiative: Cost Analyses using Claims Data from a Medicaid Managed Care Organization.
Bhaumik U; Sommer SJ; Lockridge R; Penzias R; Nethersole S; Woods ER
J Asthma; 2020 Mar; 57(3):286-294. PubMed ID: 30663906
[No Abstract] [Full Text] [Related]
36. Program-specific cost-effectiveness analysis: breast cancer screening policies for a safety-net program.
Melnikow J; Tancredi DJ; Yang Z; Ritley D; Jiang Y; Slee C; Popova S; Rylett P; Knutson K; Smalley S
Value Health; 2013; 16(6):932-41. PubMed ID: 24041343
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness of breast cancer screening programme for women in rural China.
Sun L; Sadique Z; Dos-Santos-Silva I; Yang L; Legood R
Int J Cancer; 2019 May; 144(10):2596-2604. PubMed ID: 30367451
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of breast cancer screening in women on dialysis.
Wong G; Howard K; Chapman JR; Craig JC
Am J Kidney Dis; 2008 Nov; 52(5):916-29. PubMed ID: 18789566
[TBL] [Abstract][Full Text] [Related]
39. Mobile cancer prevention and early detection outreach in Uganda: Partnering with communities toward bridging the cancer health disparities through "asset-based community development model".
Jatho A; Mugisha NM; Kafeero J; Holoya G; Okuku F; Niyonzima N
Cancer Med; 2020 Oct; 9(19):7317-7329. PubMed ID: 32810394
[TBL] [Abstract][Full Text] [Related]
40. [Evaluating the usefulness of a breast screening program in Bogotá, Colombia].
González-Mariño MA
Rev Salud Publica (Bogota); 2012; 14(1):41-52. PubMed ID: 23250314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
